USPTO serial 79448576
Reviewed by CopyMark Law Group
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Medical and scientific research, namely, conducting clinical research and clinical trials in the field of hematologic disorders; medical and scientific research in the field of hematology; scientific research, namely, pathological and molecular diagnostic research in the field of hematology; all of the foregoing provided by a foundation with its core business in conducting clinical trials, biomarker and translational studies and developing disease-specific guidelines in the field of hematologic disease. | ACTIVE | — |
| 044 | Providing medical information in the field of hematology; medical consultancy in the field of hematology; providing medical advice regarding treatment and clinical protocols in the field of hematology; all of the foregoing provided by a foundation with its core business in conducting clinical trials, biomarker and translational studies and developing disease-specific guidelines in the field of hematologic disease. | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 3, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 18, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 18, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 16, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 15, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 11, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 23, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 23, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 23, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |